全球藥品品管市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，藥品品管市場規模將從 2025 年的 66 億美元成長至 188.6 億美元，2026 年至 2034 年的複合年成長率為 12.38%。

由於監管要求日益嚴格以及藥物研發活動的不斷增加，全球藥品品管市場正穩步擴張。品管流程確保藥品的安全性、有效性以及符合國際標準。隨著學名藥藥和生物製藥產量的增加，製藥公司正大力投資先進的分析檢測解決方案。對藥品生產品質管理規範 (GMP) 的日益重視也進一步推動了對品管系統的需求。

關鍵成長要素包括層析法、光譜和分子檢測技術等分析儀器的進步。生物製藥和生物相似藥日益複雜，需要更精確的檢測和檢驗流程。此外，將品質檢測外包給受託研究機構(CRO) 的趨勢日益成長，也促進了市場成長。全球監管機構實施更嚴格的合規標準，也推動了對檢測基礎設施投資的增加。

隨著全球醫藥創新持續發展，未來前景依然強勁。個人化醫療和先進療法的興起對更精密的品管技術提出了更高的要求。在新興市場，法規結構的不斷改進進一步推動了市場需求。自動化數位資料管理系統有望提升營運效率，進而促進醫藥品管市場的永續發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球藥品品管市場：依產品分類

• 市場分析、洞察與預測
• 消耗品
• 裝置
• 服務

第5章：全球醫藥品管市場：依分析類型分類

• 市場分析、洞察與預測
• 無菌測試
• 微生物附著量測試
• 內毒素試驗
• 穩定性測試
• 萃取和洗脫試驗
• 原料測試
• 其他

第6章：全球藥品品管市場：依產品測試分類

• 市場分析、洞察與預測
• 疫苗
• 血漿製劑
• 製藥

第7章 全球醫藥品管市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • BioMerieux SA
  • SGS SA
  • Charles River Laboratories International Inc
  • WiXi AppTec
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Toxikon Corporation
  • Sartorius AG
  • REMI Group
  • Perkin Elmer

The Pharmaceutical Quality Control Market size is expected to reach USD 18.86 Billion in 2034 from USD 6.60 Billion (2025) growing at a CAGR of 12.38% during 2026-2034.

The Global Pharmaceutical Quality Control Market is expanding steadily due to stringent regulatory requirements and increasing drug development activities. Quality control processes ensure safety, efficacy, and compliance with global standards. With rising production of generic drugs and biologics, pharmaceutical companies are investing heavily in advanced analytical testing solutions. Growing emphasis on Good Manufacturing Practices (GMP) further drives demand for quality control systems.

Major growth drivers include advancements in analytical instruments such as chromatography, spectroscopy, and molecular testing technologies. The rising complexity of biologics and biosimilars requires precise testing and validation processes. Additionally, increasing outsourcing of quality testing to contract research organizations is contributing to market growth. Regulatory authorities worldwide are enforcing stricter compliance norms, boosting investment in testing infrastructure.

Future prospects remain strong as pharmaceutical innovation continues to expand globally. The growth of personalized medicine and advanced therapies will require more sophisticated quality control techniques. Emerging markets are strengthening regulatory frameworks, further driving demand. Automation and digital data management systems are expected to enhance operational efficiency, positioning the pharmaceutical quality control market for sustained development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables
• Instruments
• Services

By Analysis Type

• Sterility Testing
• Bioburden Testing
• Endotoxin Testing
• Stability Testing
• Extractable & Leachable Testing
• Raw Material Testing
• Others

By Products Tested

• Vaccines
• Plasma Products
• Drugs

COMPANIES PROFILED

• BioMerieux SA, SGS SA, Charles River Laboratories International Inc, WiXi AppTec, Merck KGaA, Thermo Fisher Scientific Inc, Toxikon Corporation, Sartorius AG, REMI Group, Perkin Elmer
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY ANALYSIS TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Analysis Type
• 5.2. Sterility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Bioburden Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Endotoxin Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Stability Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Extractable & Leachable Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Raw Material Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY PRODUCTS TESTED 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Products Tested
• 6.2. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Plasma Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PHARMACEUTICAL QUALITY CONTROL MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Analysis Type
  • 7.2.3 By Products Tested
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Analysis Type
  • 7.3.3 By Products Tested
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Analysis Type
  • 7.4.3 By Products Tested
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Analysis Type
  • 7.5.3 By Products Tested
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Analysis Type
  • 7.6.3 By Products Tested
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PHARMACEUTICAL QUALITY CONTROL INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BioMerieux SA
  • 9.2.2 SGS S.A
  • 9.2.3 Charles River Laboratories International Inc
  • 9.2.4 WiXi AppTec
  • 9.2.5 Merck KGaA
  • 9.2.6 Thermo Fisher Scientific Inc
  • 9.2.7 Toxikon Corporation
  • 9.2.8 Sartorius AG
  • 9.2.9 REMI Group
  • 9.2.10 Perkin Elmer